Menu
GeneSure™ is Genea’s pre-implantation genetic screening and testing and includes both PGD and PGS. PGD (Pre-implantation Genetic Diagnosis) and PGS (Pre-Implantation Genetic Screening) involve testing embryos created through the IVF process for genetic abnormalities. Both processes help to detect the best possible embryo for transfer.
Genea’s highly trained and experienced scientists microscopically remove a few cells from the embryo and test the DNA. An embryo free of abnormalities is then transferred to the woman as part of the normal IVF process or stays frozen for future use. The difference between PGD and PGS is how and what they screen for.
PGD (Pre-implantation Genetic Diagnosis) is often used by people who don’t have an infertility issue but know they carry a serious genetic disorder. PGD gives them the chance to have a child free of the condition. To get started with PGD, our scientists need to do a genetic work up. This involves blood samples from each partner and may require additional samples from other family members. Through this work up process, our scientists can identify all the affected and non-affected DNA patterns in the patient’s embryos.
At Genea, we have experience with more than 350 genetic diseases as part of our PGD program so far. These conditions are often disabling, have no prevention, cure or proven treatments beyond symptomatic care. Some examples of the sorts of conditions we can screen for with PGD are Cystic fibrosis, Duchenne muscular dystrophy, Huntington disease, Leigh’s disease and Fragile X. PGD also screens for Thalassemia which is the most common single gene disorder among Asian screened for at Genea.
PGS, is often used by couples who are older, have experienced recurrent miscarriage or have had a number of failed embryo transfers following IVF treatment. It doesn’t require a genetic work up but rather screens embryos to ensure they have the correct number and order of chromosomes.
PGS maximises patients’ potential to have a baby by reducing miscarriage rates* and increasing live birth rates*
Learn more about PGD and PGS please refer to : https://www.genea.com.au/patients/understanding-pgd
PGD/PGS does not provide 100 percent accuracy due to the various technical difficulties that can be experienced. We recommend that prenatal diagnostic tests are discussed with your referring doctor.
Genea’s GeneSyte™ prenatal genetic screening is a blood test that a pregnant woman can undertake in the first trimester of pregnancy, to look for chromosome errors that her baby may have. The most commonly known chromosome error is Down syndrome (Trisomy 21). For such an important test, you’ll want to have the best.
It’s therefore important to know that GeneSyte™:
– has the lowest “failure to report” rate of any pre-natal tests on the market
– results are provided 99.9% of the time
– we don’t just provide risk scores (like some tests do), we give a result – in other words, we give you an answer.
